Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 12, 2013, Pages

  Pan, H Q ^a,b   Bele, S ^b   Feng, Y ^b   Qiu, S S ^b   Lu J Q ^b   Tang, S W ^b   Shen, H B ^b   Wang, Jian Ming ^b   Zhu, Li Mei ^c  

^a Third Hospital of Zhenjiang City   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Economic burden; Pulmonary tuberculosis; Risk factors

Indexed keywords

LIVER PROTECTIVE AGENT; TUBERCULOSTATIC AGENT;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; DELAYED DIAGNOSIS; DRUG COST; FEMALE; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL POPULATION; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HOSPITAL COSTS; HUMANS; INCOME; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RURAL HEALTH SERVICES; SICK LEAVE; TUBERCULOSIS; YOUNG ADULT;

EID: 84888081837     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0144     Document Type: Article

References (25)

1. World Health Organization. Global tuberculosis report 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012. http://www.who.int/tb/ publications/global-report/en/ Accessed August 2013.
2. Frieden T R, Sterling T R, Munsiff S S, Watt C J, Dye C. Tuberculosis. Lancet 2003; 362: 887-899. (Pubitemid 37130100)
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
4. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2009. http://www.who.int/tb/features-archive/new-treatment-guidelines-may2010/ en/index.html Accessed August 2013.
5. Akachi Y, Zumla A, Atun R. Investing in improved performance of national tuberculosis programs reduces the tuberculosis burden: analysis of 22 high-burden countries, 2002-2009. J Infect Dis 2012; 205 (Suppl 2): S284-S292.
6. Long Q, Smith H, Zhang T, Tang S, Garner P. Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health 2011; 11: 393.
7. Xu B, Fochsen G, Xiu Y, Thorson A, Kemp J R, Jiang Q W. Perceptions and experiences of health care seeking and access to TB care - a qualitative study in rural Jiangsu Province, China. Health Policy 2004; 69: 139-149. (Pubitemid 38798437)
8. Zhang T, Liu X, Bromley H, Tang S. Perceptions of tuberculosis and health seeking behaviour in rural Inner Mongolia, China. Health Policy 2007; 81: 155-165. (Pubitemid 46436178)
9. Liu Y, Hsiao W C, Eggleston K. Equity in health and health care: the Chinese experience. Soc Sci Med 1999; 49: 1349-1356. (Pubitemid 29447282)
10. Zhang T, Tang S, Jun G, Whitehead M. Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups. BMC Public Health 2007; 7: 19.
11. Liu X, Thomson R, Gong Y, et al. How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives. Trop Med Int Health 2007; 12: 1464-1471. (Pubitemid 350212712)
12. Barter D M, Agboola S O, Murray M B, Barnighausen T. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa - a systematic review. BMC Public Health 2012; 12: 980.
13. Laxminarayan R, Klein E, Dye C, Floyd K, Darley S, Adeyi O. Economic benefits of tuberculosis control. Washington DC, USA: The World Bank, 2007. http://econ.worldbank.org/external/default/main?pagePK=64165259&theSitePK= 469382&piPK=64165421&menuPK=64166093&entityID=000158349- 20070801103922 Accessed August 2013.
14. Meng Q, Li R, Cheng G, Blas E. Provision and financial burden of TB services in a financially decentralized system: a case study from Shandong, China. Int J Health Plann Manage 2004; 19 (Suppl 1): S45-S62. (Pubitemid 40201956)
15. Tang S, Squire S B. What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective. Health Policy 2005; 72: 93-104. (Pubitemid 40349011)
16. Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res 2009; 9: 169.
17. Nodieva A, Jansone I, Broka L, Pole I, Skenders G, Baumanis V. Recent nosocomial transmission and genotypes of multi-drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2010; 14: 427-433.
18. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland: WHO, 2010.
19. Yan F, Thomson R, Tang S, et al. Multiple perspectives on diagnosis delay for tuberculosis from key stakeholders in poor rural China: case study in four provinces. Health Policy 2007; 82: 186-199. (Pubitemid 46777055)
20. Shang P, Xia Y, Liu F, et al. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLOS ONE 2011; 6: e21836.
21. Xia Y Y, Zhan S Y. [Systematic review of anti-tuberculosis drug induced adverse reactions in China]. Zhonghua Jie He He Hu Xi Za Zhi 2007; 30: 419-423. [Chinese]
22. Li Q, Cao X, Zhao G, Zhang L, Xu L. [Analysis on economic burden of disease and its influencing factors of pulmonary tuberculosis patient in Shandong Province]. Chinese Health Economics 2010; 29: 71-73. [Chinese]
23. Wang J, Shen H. Direct observation and completion of treatment of tuberculosis in rural areas of China. Scand J Public Health 2009; 37: 304-309.
24. Millet J P, Moreno A, Fina L, et al. Factors that influence current tuberculosis epidemiology. Eur Spine J 2013; 22 (Suppl 4): 539-548.
25. Floyd K. Costs and effectiveness - the impact of economic studies on TB control. Tuberculosis (Edinb) 2003; 83: 187-200. (Pubitemid 36683571)